Medical Condition News

RSS

Michigan Tech study: Fish oil supplements may protect the heart in stressful situations

Fish oil supplements may protect the heart in stressful situations, according to a recent study. Jason Carter, a researcher at Michigan Technological University, conducted the study with 67 healthy volunteer test participants in their 20s.

5 Jun 2013

Johns Hopkins researchers find interstate variations in rates of emergency bowel surgeries

Johns Hopkins researchers have documented huge and somewhat puzzling interstate variations in the percentage of emergency versus elective bowel surgeries. Figuring out precisely why the differences occur is critical, they say, because people forced to undergo emergency procedures are far more likely to die from their operations than those able to plan ahead for them.

5 Jun 2013

Study reveals how type 2 diabetes and CVD increase risk of cognitive decline

People suffering from type 2 diabetes and cardiovascular disease are at an increased risk of cognitive decline, according to a new study from Wake Forest Baptist Medical Center.

5 Jun 2013

Living in neighborhoods can make measurable difference in preventing obesity, study finds

Living in a neighborhood that supports a healthy lifestyle can make a measurable difference in preventing obesity, according to a longitudinal study recently published in the journal Obesity.

5 Jun 2013

Duke researchers find novel way to repair gene responsible for Duchenne muscular dystrophy

Using a novel genetic 'editing' technique, Duke University biomedical engineers have been able to repair a defect responsible for one of the most common inherited disorders, Duchenne muscular dystrophy, in cell samples from Duchenne patients.

5 Jun 2013

Revised CPG on treatment of osteoarthritis of the knee addresses two key changes

The American Academy of Orthopaedic Surgeons recently released its revised clinical practice guideline on the treatment of osteoarthritis of the knee, addressing two key changes.

5 Jun 2013

Researchers demonstrate how modified citrus pectin works against cancer

A new review by researchers at the University of Maryland School of Medicine highlights a large body of published research demonstrating how modified citrus pectin, works against cancer.

4 Jun 2013

seca releases medical Body Composition Analyzer

seca, the world's market leader in medical measuring and weighing, launches its medical Body Composition Analyzer, the seca mBCA 514.

From seca 4 Jun 2013

Zalicus advancing Z944 into further clinical development

Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain, today announced that it is advancing Z944, its novel oral T-type calcium channel blocker, into further clinical development in the third quarter of 2013.

4 Jun 2013

Canadian researcher develops first animal model to study function of C9ORF72 in ALS

Canadian researcher Edor Kabashi of the Université de Montréal has developed the first animal model to study the function of a gene responsible for the highest percentage of ALS, commonly known as Lou Gehrig's disease. Results to date shed light on the cause of the devastating disease.

4 Jun 2013

Weather conditions do not affect fibromyalgia pain or fatigue

Dutch researchers report that weather conditions including temperature, sunshine, and precipitation have no impact on fibromyalgia symptoms in female patients. Results published in published in Arthritis Care & Research, a journal of the American College of Rheumatology (ACR), suggest that individual patients may be sensitive to some changes in the weather.

4 Jun 2013

PROLOR Biotech announces initiation of hGH-CTP Phase III trial in growth hormone deficient adults

PROLOR Biotech, Inc., a company developing next-generation biobetter therapeutic proteins, today announced the initiation of a pivotal Phase III clinical trial of hGH-CTP, the company's proprietary version of human growth hormone, in growth hormone deficient adults.

4 Jun 2013

Naurex initiates Phase I trial of NRX-1074 in normal volunteers

Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced that it has begun patient dosing in a Phase I trial of its novel, orally active agent NRX-1074.

4 Jun 2013

American Academy of Otolaryngology publishes new guideline on “Improving Voice Outcomes after Thyroid Surgery”

The American Academy of Otolaryngology-Head and Neck Surgery Foundation on Tuesday published a new Clinical Practice Guideline on "Improving Voice Outcomes after Thyroid Surgery" to recognize the importance of the patient's voice and the potential impact thyroid surgery can have on it.

4 Jun 2013

PCORI awards $2.1M to USF college of nursing to study a new approach for cancer management

The Patient-Centered Outcomes Research Institute (PCORI) has approved a $2.1-million award to the University of South Florida College of Nursing to study "Patient Outcomes of a Self-care Management Approach to Cancer Symptoms: A Clinical Trial." USF Distinguished Professor and Thompson Professor of Oncology Nursing Susan C. McMillan, PhD, ARNP, FAAN, will lead the research project.

4 Jun 2013

Employees who face high emotional demand, conflicting roles are more likely to report psychological distress

Employees who face high emotional demand and conflicting roles are more likely to report psychological distress—placing them at higher risk of mental health disorders and reduced productivity, reports a study in the June Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine (ACOEM).

4 Jun 2013

Integrity Applications' GlucoTrack DF-F glucose monitoring device gets CE Mark approval

Integrity Applications, Inc. announced today that it has received CE Mark approval for its GlucoTrack DF-F non-invasive blood glucose measurement device.

4 Jun 2013

New technique selectively represses unwanted immune reactions without disabling immune system

The human immune system is remarkably efficient, but sometimes its attack is misdirected, leading to allergies, autoimmune diseases and rejection of transplant organs and therapeutic drugs. Current immune suppressants have major drawbacks, but a team from The Scripps Research Institute (TSRI) has demonstrated a new technique that may lead to a better way to selectively repress unwanted immune reactions without disabling the immune system as a whole.

4 Jun 2013

Tel Aviv University researchers find protein modification may help control Alzheimer's and epilepsy

In the brain, cell-to-cell communication is dependent on neurotransmitters, chemicals that aid the transfer of information between neurons. Several proteins have the ability to modify the production of these chemicals by either increasing or decreasing their amount, or promoting or preventing their secretion.

4 Jun 2013

OxThera granted Japanese patents for treating oxalate-related disease

OxThera AB has been granted three Japanese patents during 2012 and 2013. The patents will secure the pharmaceutical composition and the method for treating and preventing oxalate-related disease with micro-organisms and enzymes and will further strengthen the Company's patent estate for this unmet medical need.

4 Jun 2013

Medical Condition News

Michigan Tech study: Fish oil supplements may protect the heart in stressful situations

Johns Hopkins researchers find interstate variations in rates of emergency bowel surgeries

Study reveals how type 2 diabetes and CVD increase risk of cognitive decline

Living in neighborhoods can make measurable difference in preventing obesity, study finds

Duke researchers find novel way to repair gene responsible for Duchenne muscular dystrophy

Revised CPG on treatment of osteoarthritis of the knee addresses two key changes

Researchers demonstrate how modified citrus pectin works against cancer

seca releases medical Body Composition Analyzer

Zalicus advancing Z944 into further clinical development

Canadian researcher develops first animal model to study function of C9ORF72 in ALS

Weather conditions do not affect fibromyalgia pain or fatigue

PROLOR Biotech announces initiation of hGH-CTP Phase III trial in growth hormone deficient adults

Naurex initiates Phase I trial of NRX-1074 in normal volunteers

American Academy of Otolaryngology publishes new guideline on “Improving Voice Outcomes after Thyroid Surgery”

PCORI awards $2.1M to USF college of nursing to study a new approach for cancer management

Employees who face high emotional demand, conflicting roles are more likely to report psychological distress

Integrity Applications' GlucoTrack DF-F glucose monitoring device gets CE Mark approval

New technique selectively represses unwanted immune reactions without disabling immune system

Tel Aviv University researchers find protein modification may help control Alzheimer's and epilepsy

OxThera granted Japanese patents for treating oxalate-related disease

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Latest News